| __timestamp | Alpine Immune Sciences, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 4733600000 |
| Thursday, January 1, 2015 | 16054000 | 4796400000 |
| Friday, January 1, 2016 | 23316000 | 5243900000 |
| Sunday, January 1, 2017 | 10626000 | 5281800000 |
| Monday, January 1, 2018 | 28970000 | 5051200000 |
| Tuesday, January 1, 2019 | 35847000 | 5595000000 |
| Wednesday, January 1, 2020 | 27185000 | 6085700000 |
| Friday, January 1, 2021 | 58742000 | 7025900000 |
| Saturday, January 1, 2022 | 70243000 | 7190800000 |
| Sunday, January 1, 2023 | 80904000 | 9313400000 |
| Monday, January 1, 2024 | 14271000000 |
Data in motion
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) investments are pivotal. Over the past decade, Eli Lilly and Company and Alpine Immune Sciences, Inc. have demonstrated contrasting yet intriguing R&D trajectories. Eli Lilly, a stalwart in the industry, has consistently invested heavily, with a notable 97% increase in R&D expenses from 2014 to 2023. This commitment underscores their dedication to innovation and maintaining a competitive edge.
Conversely, Alpine Immune Sciences, a burgeoning player, has shown a remarkable 563% surge in R&D spending over the same period. This exponential growth reflects their aggressive pursuit of breakthroughs in immune sciences. While Eli Lilly's R&D budget dwarfs Alpine's, the latter's rapid growth trajectory is a testament to its ambition and potential impact on the industry. As we look to the future, these investments will likely shape the next wave of medical advancements.
Research and Development Expenses Breakdown: Eli Lilly and Company vs GSK plc
Research and Development Investment: Eli Lilly and Company vs Sanofi
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
Comparing Innovation Spending: Eli Lilly and Company and MorphoSys AG
Comparing Innovation Spending: Eli Lilly and Company and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Alpine Immune Sciences, Inc.
Research and Development Investment: Amgen Inc. vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Exelixis, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CRISPR Therapeutics AG
Alpine Immune Sciences, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?